TR201104008T1 - Bir antitümör ilacının oluşturulmasına ve stabilizasyonuna ilişkin yöntemler. - Google Patents

Bir antitümör ilacının oluşturulmasına ve stabilizasyonuna ilişkin yöntemler.

Info

Publication number
TR201104008T1
TR201104008T1 TR2011/04008T TR201104008T TR201104008T1 TR 201104008 T1 TR201104008 T1 TR 201104008T1 TR 2011/04008 T TR2011/04008 T TR 2011/04008T TR 201104008 T TR201104008 T TR 201104008T TR 201104008 T1 TR201104008 T1 TR 201104008T1
Authority
TR
Turkey
Prior art keywords
methods
stabilizing
forming
antitumor drug
medicament
Prior art date
Application number
TR2011/04008T
Other languages
English (en)
Turkish (tr)
Inventor
Sergeevich Sokyrko Oleg
Nikolaevna Maydanevich Nadezhda
Iliodorovna Volchenskova Ilima
Original Assignee
Sergeevich Sokyrko Oleg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from UAA200906849A external-priority patent/UA90233C2/uk
Application filed by Sergeevich Sokyrko Oleg filed Critical Sergeevich Sokyrko Oleg
Publication of TR201104008T1 publication Critical patent/TR201104008T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR2011/04008T 2008-12-22 2009-11-23 Bir antitümör ilacının oluşturulmasına ve stabilizasyonuna ilişkin yöntemler. TR201104008T1 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
UA200814666 2008-12-22
UAA200906849A UA90233C2 (uk) 2009-06-30 2009-06-30 Спосіб стабілізації протипухлинних засобів на основі водного розчину сполуки платини з дезоксирибонуклеїновою кислотою

Publications (1)

Publication Number Publication Date
TR201104008T1 true TR201104008T1 (tr) 2011-10-21

Family

ID=42288021

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/04008T TR201104008T1 (tr) 2008-12-22 2009-11-23 Bir antitümör ilacının oluşturulmasına ve stabilizasyonuna ilişkin yöntemler.

Country Status (8)

Country Link
CN (1) CN102227222B (pt)
BG (1) BG66625B1 (pt)
BR (1) BRPI0923273A2 (pt)
EA (1) EA015680B1 (pt)
IL (1) IL213446A (pt)
PL (1) PL219734B1 (pt)
TR (1) TR201104008T1 (pt)
WO (1) WO2010074662A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102784098A (zh) * 2011-05-20 2012-11-21 湖南省湘中制药有限公司 丙戊酸镁注射液及其制备工艺
CN104937096B (zh) * 2013-01-04 2019-11-05 德克萨斯系统大学董事会 包含柠檬酸的组合物及其应用
CN104027301B (zh) * 2013-03-05 2017-05-10 肖云彩 一种奥拉西坦组合物注射液
RU2667128C2 (ru) 2016-12-29 2018-09-14 Герман Петрович Беккер Композиция для приготовления противоопухолевого средства и способ приготовления противоопухолевого средства на ее основе

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5534513A (en) * 1991-09-05 1996-07-09 Taiho Pharmaceutical Company, Ltd. Antitumor potentiator and antitumor composition
UA70455A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Antineoplastic platinum drug for topical treatmentantineoplastic platinum drug for topical treatment of oropharyngeal cancer and method for its usage of oropharyngeal cancer and method for its usage
UA70456A (en) * 2003-09-23 2004-10-15 Serhii Oleksandrovych Shalimov Dosage form of infusional antineoplastic drug and dosage form of infusional antineoplastic drug and method for its production method for its production

Also Published As

Publication number Publication date
CN102227222B (zh) 2012-11-21
BG66625B1 (bg) 2017-12-15
BG110926A (bg) 2011-10-31
IL213446A0 (en) 2011-07-31
PL394863A1 (pl) 2011-09-26
PL219734B1 (pl) 2015-07-31
IL213446A (en) 2013-11-28
EA201100618A1 (ru) 2011-10-31
WO2010074662A1 (ru) 2010-07-01
BRPI0923273A2 (pt) 2014-01-28
EA015680B1 (ru) 2011-10-31
CN102227222A (zh) 2011-10-26

Similar Documents

Publication Publication Date Title
CY1124928T1 (el) Αναστολεις πυραζολυλο κινοξαλινο κινασης
CY1121646T1 (el) Παραγωγα μορφινανης για την αγωγη υπερβολικης δοσης ναρκωτικων
DE602006014579D1 (de) Heteroalkylgebundene pyrimidinderivate
CY1118061T1 (el) Δικυκλικα παραγωγα heterocyclyl σαν καταστολεις κινασης (kinase) fgfr για θεραπευτικη χρηση
MX2009013835A (es) Forma de dosis estabilizada de picoplatino.
EA201200952A1 (ru) Производные пиразина и их применение для лечения неврологических нарушений
EA201490891A1 (ru) Пиридопиразины, обладающие противораковой активностью через ингибирование fgfr киназ
MX2009009537A (es) Nanoparticula que comprende rapamicina y albumina como agente anticancer.
EA201100971A1 (ru) Производные пиримидининдола для лечения злокачественного новообразования
EA201790267A1 (ru) Новые модуляторы киназ
SG178919A1 (en) Sustituted ( heteroarylmethyl ) thiohydantoins as anticancer drugs
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
EA201170753A1 (ru) Налмефена гидрохлорид дигидрат
PH12015501088A1 (en) Dimeric compounds
MX2015004362A (es) Derivados de ketamina.
EA201001747A1 (ru) Бензоксазиноновые производные, действующие в качестве агониста бета-2-адренорецептора, для лечения респираторных расстройств
MX2018006953A (es) Compuestos de platino funcionalizados con monomaleimida para la terapia del cancer.
EA201171366A1 (ru) Противоопухолевая комбинация, содержащая ave8062 и сорафениб
MX2011008195A (es) Derivados de indol como agentes anticancer.
RU2014117707A (ru) Способ лечения пролиферативного заболевания
TR201104008T1 (tr) Bir antitümör ilacının oluşturulmasına ve stabilizasyonuna ilişkin yöntemler.
BR112013009260A2 (pt) compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase
SMT201300112B (it) Sale citrato di 9E-15-(2-pirrolidin-1-il-etossi)-7,12,25-triossa-19,21,24-triaza-tetracicloÄ18.3.1.1(2,5).1(14,18)Üesacos a-1(24),2,4,9,14,16,18(26),20,22-nonaene
MX2018004696A (es) Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos.